By Professor Jason Grebely

Journal articles

Smith KR; Suppiah V; O''Connor K; Berg T; Weltman M; Abate ML; Spengler U; Bassendine M; Matthews G; Irving W; Powell E; Riordan S; Ahlensteil G; Stewart GJ; Bahlo M; Booth DR; George J, 2011, 'Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort', Genome Medicine, 3, pp. 57

Grebely J; Raffa JD; Lai C; Kerr T; Fischer B; Krajden M; Dore GJ; Tyndall MW, 2011, 'Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents', Journal of Viral Hepatitis, 18, pp. 32 - 41, http://dx.doi.org/10.1111/j.1365-2893.2010.01279.x

Grebely J; Tyndall M, 2011, 'Management of HCV and HIV infections among people who inject drugs', Current opinion in HIV & AIDS, 6, pp. 501 - 507, http://dx.doi.org/10.1097/COH.0b013e32834bcb36

Sacks-Davis R; Daraganova G; Aitken C; Higgs P; Tracy L; Bowden D; Robins G; Pattison P; Grebely J; Barry A; Hellard M, 2011, 'MOLECULAR EPIDEMIOLOGY OF HEPATITIS C IN A SOCIAL NETWORK OF YOUNG PEOPLE WHO INJECT DRUGS', JOURNAL OF HEPATOLOGY, 54, pp. S465 - S466, http://dx.doi.org/10.1016/S0168-8278(11)61180-X

Matthews G; Pham STP; Hellard M; Grebely J; Zhang L; Oon A; Marks P; Van Beek IA; Rawlinson WD; Kaldor JM; Lloyd AR; Dore GJ; White PA, 2011, 'Patterns and characteristics of Hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian Trial in Acute Hepatitis C', Clinical Infectious Diseases, 52, pp. 803 - 811, http://dx.doi.org/10.1093/cid/ciq200

Grebely J; Dore GJ, 2011, 'Prevention of hepatitis C virus in injecting drug users: A narrow window of opportunity', Journal of Infectious Diseases, 203, pp. 571 - 574

Grebely J; Matthews G; Dore GJ, 2011, 'Treatment of acute HCV infection', Nature Reviews Gastroenterology and Hepatology, 8, pp. 265 - 274, http://dx.doi.org/10.1038/nrgastro.2011.32

Grebely J; Dore GJ, 2011, 'What is killing people with HCV infection?', Seminars in Liver Disease, 31, pp. 331 - 339

Grebely J; Matthews GV; Petoumenos K; Dore GJ, 2010, 'Spontaneous clearance and the beneficial impact of treatment on clearance during recent hepatitis C virus infection', Journal of Viral Hepatitis, 17, pp. 896, http://dx.doi.org/10.1111/j.1365-2893.2009.01256.x

Dore G; Grebely J; Gillman A; Thein R; Day C; Ryan L; Treloar C; Haber P, 2010, 'PRESENTER 1: OVERVIEW OF TREATMENT OF HEPATITIS C (HCV) IN THE OPIATE PHARMACOTHERAPY SETTING AND THE ENHANCING TREATMENT OF HEPATITIS C IN THE OPIATE SUBSTITUTION SETTING (ETHOS) PARTNERSHIP INITIATIVE', DRUG AND ALCOHOL REVIEW, 29, pp. 21 - 21, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000284895600048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Grebely J; Bryant J; Hull P; Hopwood M; Dore G; Treloar C, 2010, 'PRESENTER 2: SPECIALIST ASSESSMENT AND TREATMENT OF HEPATITIS C VIRUS INFECTION AMONG INJECTION DRUG USERS IN NEW SOUTH WALES, AUSTRALIA', DRUG AND ALCOHOL REVIEW, 29, pp. 21 - 21, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000284895600049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dore GJ; Hellard M; Matthews G; Grebely J; Haber PS; Petoumenos K; Yeung B; Marks P; Van Beek IA; McCaughan G; White PA; French R; Rawlinson WD; Lloyd AROLA; Kaldor JM; Dolan K, 2010, 'Effective treatment of injecting drug users with recently acquired hepatitis C virus infection', Gastroenterology, 138, pp. 123 - 135, http://dx.doi.org/10.1053/j.gastro.2009.09.019

Grebely J; Petoumenos K; Matthews G; Haber PS; Marks P; Lloyd AROLA; Kaldor JM; Dore GJ; Hellard M; Dolan K, 2010, 'Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study', Drug and Alcohol Dependence, 107, pp. 244 - 249, http://dx.doi.org/10.1016/j.drugalcdep.2009.09.015

Grebely J; Knight E; Genoway K; Viljoen M; Khara M; Elliott D; Gallagher L; Storms M; Raffa J; DeVlaming S; Duncan F; Conway B, 2010, 'Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support', European Journal of Gastroenterology and Hepatology, 22, pp. 270 - 277

Grebely J; Petoumenos K; Hellard M; Matthews G; Suppiah V; Applegate TL; Yeung B; Marks P; Rawlinson WD; Lloyd AROLA; Booth D; Kaldor JM; George J; Dore GJ; Amin J; Cameron B; Acraman B; Dolan K; Bloch M; Van Beek I; Li H; Madden A, 2010, 'Potential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus Infection', Hepatology, 52, pp. 1216 - 1224, http://dx.doi.org/10.1002/hep.23850

Grebely J; Knight E; Ngai T; Genoway K; Raffa J; Storms M; Gallagher L; Krajden M; Dore GJ; Duncan F; Conway B, 2010, 'Reinfection with hepatitis C virus following sustained virological response in injection drug users', Journal of Gastroenterology and Hepatology, 25, pp. 1281 - 1284, http://dx.doi.org/10.1111/j.1440-1746.2010.06238.x

Haber P; Hellard M; Matthews GV; Grebely J; Petoumenos K; Yeung B; Marks P; Van Beek I; Kaldor J; Dore GJ, 2009, 'TREATMENT OF RECENT HEPATITIS C VIRUS INFECTION IN A PREDOMINANTLY INJECTION DRUG USER COHORT: THE ATAHC STUDY', DRUG AND ALCOHOL REVIEW, 28, pp. A27 - A27, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300083&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B, 2009, 'Primary drug resistance in antiretroviral-naïve injection drug users', International Journal of Infectious Diseases, 13, pp. 577 - 583, http://dx.doi.org/10.1016/j.ijid.2008.08.028

Grebely J; Thomas D; Dore GJ, 2009, 'HCV reinfection studies and the door to vaccine development', Journal of Hepatology, 51, pp. 628 - 631

Grebely J; Raffa J; Krajden M; Kerr TH; Fischer B; Tyndall M, 2009, 'Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents', Journal of Viral Hepatitis, 16, pp. 352 - 358

Brooke R; Tang P; Mak A; Grebely J; Adie K; Danta M; Spinelli J; Andonov A; Krajden M, 2009, 'P214 Molecular epidemiology of newly acquired hepatitis C virus (HCV) infections in British Columbia', International Journal of Antimicrobial Agents, 34, pp. S95 - S95, http://dx.doi.org/10.1016/s0924-8579(09)70433-9

Tossonian H; Raffa J; Grebely J; Viljoen M; Mead A; Khara M; Mclean M; Krishnamurthy A; DeVlaming S; Conway B, 2009, 'Primary drug resistance in chronically infected antiretroviral-naïve injection drug users.', International Journal of Infectious Diseases, 13, pp. 577 - 583

Grebely J; Knight E; Ngai T; Genoway KA; Raffa JD; Storms M; Gallagher L; Krajden M; Dore GJ; Duncan F; Conway B, 2009, 'Reinfection with hepatitis C virus following sustained virological response in injection drug users', Journal of Gastroenterology and Hepatology, pp. no - no, http://dx.doi.org/10.1111/j.1440-1746.2009.06238.x

Conway B; Tossonian H; Raffa J; Storms M; Duncan F; Grebely J, 2009, 'Systematic approach to the treatment of HCV infection in injection drug users: where are we now?', Future Virology, 4, pp. 411 - 413, http://www.futuremedicine.com/

Haber P; Hellard M; Matthews GV; Grebely J; Petoumenos K; Yeung B; Marks P; van Beek I; McCaughan G; White PA; Ffrench R; Rawlinson W; Lloyd A; Kaldor J; Dore GJ, 2009, 'Treatment of recent hepatitis C virus infection in a predominantly injection drug user cohort: the ATAHC Study', The Canadian Journal of Addiction, 1, pp. 33 - 33, http://dx.doi.org/10.1097/02024458-200912000-00072

Grebely J; Raffa JD; Lai C; Kerr T; Krajden M; Kerr T; Dore GJ; Tyndall MW, 2008, 'Impact of HCV and HIV infections on mortality in a large community-based cohort of inner city residents', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 23, pp. A379 - A380, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000264953600118&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Raffa JD; Tossonian HK; Grebely J; Petkau AJ; Devlaming S; Conway B, 2008, 'Intermediate highly active antiretroviral therapy adherence thresholds and empirical models for the development of drug resistance mutations', Journal of Acquired Immune Deficiency Syndromes, 47, pp. 397 - 399, http://dx.doi.org/10.1097/QAI.0b013e31815b0d35

Grebely J; Devlaming S; Duncan F; Viljoen M; Conway B, 2008, 'Current approaches to HCV infection in current and former injection drug users', Journal of Addictive Diseases, 27, pp. 25 - 35, http://dx.doi.org/10.1300/J069v27n02_04

Grebely J; Genoway KA; Raffa JD; Dhadwal G; Rajan T; Showler G; Kalousek K; Duncan F; Tyndall MW; Fraser C; Conway B; Fischer B, 2008, 'Barriers associated with the treatment of hepatitis C virus infection among illicit drug users', Drug and Alcohol Dependence, 93, pp. 141 - 147, http://dx.doi.org/10.1016/j.drugalcdep.2007.09.008

Grebely J; Gallagher L; Knight E; Genoway K; Storms M; Tossonian HK; Hosseina M; Showler G; Raffa JD; Fraser C; Duncan F; Conway B, 2008, 'Substitution of tenofovir for nucleoside analogues in virologically controlled HIV-infected patients co-infected with hepatitis C virus: TEN-SWITCH', Journal of the International AIDS Society, 11, pp. P277 - P277, http://dx.doi.org/10.1186/1758-2652-11-s1-p277

Matthews G; Grebely J; Dore GJ, 2008, 'The role of re-infection in determining rates of spontaneous clearance after hepatitis C exposure', Journal of Hepatology, 49, pp. 305 - 307, http://dx.doi.org/10.1016/j.jhep.2008.06.005

Grebely J; Genoway K; Khara M; Duncan F; Viljoen M; Elliott D; Raffa JD; DeVlaming S; Conway B, 2007, 'Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection', International Journal of Drug Policy, 18, pp. 437 - 443, http://dx.doi.org/10.1016/j.drugpo.2007.01.009

Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B, 2007, 'The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program', Drug and Alcohol Dependence, 89, pp. 306 - 309, http://dx.doi.org/10.1016/j.drugalcdep.2007.02.007

Tossonian HK; Raffa JD; Grebely J; Trotter B; Viljoen M; Mead A; Khara M; McLean M; Duncan F; Fraser C; DeVlaming S; Conway B, 2007, 'Methadone dosing strategies in HIV-infected injection drug users enrolled in a directly observed therapy program', Journal of Acquired Immune Deficiency Syndromes, 45, pp. 324 - 327, http://dx.doi.org/10.1097/QAI.0b013e318061b5fd

Grebely J; Conway B; Raffa JD; Lai C; Krajden M; Tyndall MW, 2007, 'Reply [2]', Hepatology, 45, pp. 1331, http://dx.doi.org/10.1002/hep.21602

Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; Devlaming S; Conway B, 2007, 'Clinical implications of mutations at reverse transcriptase codon 135 on response to NNRTI-based therapy', The open virology journal, 1, pp. 8 - 13, http://dx.doi.org/10.2174/1874357900701010008

Grebely J; Raffa JD; Meagher C; Duncan F; Genoway KA; Khara M; McLean M; Mead A; Viljoen M; DeVlaming S; Fraser C; Conway B, 2007, 'Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug users', Journal of Gastroenterology and Hepatology Australia, 22, pp. 1519 - 1525, http://dx.doi.org/10.1111/j.1440-1746.2007.05032.x

Crebely J; Raffa JD; Lai C; Krajden M; Conway B; Tyndall MW, 2007, 'Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users', Canadian Journal of Gastroenterology, 21, pp. 447 - 451, http://dx.doi.org/10.1155/2007/796325

Grebely J; Conway B; Raffa JD; Lai C; Krajden M; Tyndall MW, 2006, 'Hepatitis C virus reinfection in injection drug users', Hepatology, 44, pp. 1139 - 1145, http://dx.doi.org/10.1002/hep.21376

Conway B; Grebely J; Duncan F, 2006, 'Time for a systematic approach to the treatment of hepatitis C virus infection in injection drug users', FUTURE VIROLOGY, 1, pp. 139 - 141, http://dx.doi.org/10.2217/17460794.1.2.139

Grebely J; Conway B; Raffa J; Lai C; Krajden M; Tyndall MW, 2006, 'Uptake of hepatitis C virus (HCV) treatment among injection drug users (IDUS) in Vancouver, Canada', JOURNAL OF HEPATOLOGY, 44, pp. S214 - S215, http://dx.doi.org/10.1016/S0168-8278(06)80578-7

Conway B; Grebely J; Tossonian H; Lefebvre D; De Vlaming S, 2005, 'A systematic approach to the treatment of HIV and hepatitis C virus infection in the inner city: A Canadian perspective', Clinical Infectious Diseases, 41, pp. S73 - S78, http://dx.doi.org/10.1086/429500

Back to profile page